Results 171 to 180 of about 364,170 (283)

Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C [PDF]

open access: bronze, 2000
Marcus Wiedmann   +8 more
openalex   +1 more source

Rice‐derived SARS‐CoV‐2 glycoprotein S1 subunit vaccine elicits humoral and cellular immune responses

open access: yesPlant Biotechnology Journal, EarlyView.
Summary Since 2019, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the virus causing COVID‐19, has been spreading and mutating globally despite the expedited approval of many commercial vaccines. Therefore, developing safe, effective and affordable vaccines remains essential to meet the global demand, particularly in developing countries.
Li Song   +14 more
wiley   +1 more source

Hepatitis B vaccine coverage in health care students: a cross-sectional study in Vietnam. [PDF]

open access: yesPLoS One
Vo LT   +6 more
europepmc   +1 more source

Enhancing B- and T-Cell Immune Response to a Hepatitis C Virus E2 DNA Vaccine by Intramuscular Electrical Gene Transfer [PDF]

open access: green, 2000
S. Zucchelli   +10 more
openalex   +1 more source

Severe pancytopenia triggered by recombinant hepatitis B vaccine [PDF]

open access: bronze, 2000
Jean‐François Viallard   +7 more
openalex   +1 more source

Attitudes of the Population Toward Vaccines During the COVID‐19 Pandemic: The PROACTIVE Study

open access: yesPublic Health Nursing, EarlyView.
ABSTRACT Background Vaccination is a vital strategy to prevent infectious diseases and reduce mortality globally. However, vaccine hesitancy threatens these efforts, especially highlighted during the COVID‐19 pandemic. Understanding factors influencing vaccination decisions is crucial for improving public health strategies.
Michela Calzolari   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy